Revvity Shares Outstanding 2010-2025 | RVTY
Revvity shares outstanding history from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Revvity shares outstanding for the quarter ending March 31, 2025 were 0.120B, a 2.68% decline year-over-year.
- Revvity 2024 shares outstanding were 0.123B, a 1.59% decline from 2023.
- Revvity 2023 shares outstanding were 0.125B, a 1.28% decline from 2022.
- Revvity 2022 shares outstanding were 0.126B, a 8.36% increase from 2021.
| Revvity Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 123 |
| 2023 | 125 |
| 2022 | 126 |
| 2021 | 117 |
| 2020 | 112 |
| 2019 | 112 |
| 2018 | 112 |
| 2017 | 111 |
| 2016 | 110 |
| 2015 | 113 |
| 2014 | 114 |
| 2013 | 114 |
| 2012 | 115 |
| 2011 | 114 |
| 2010 | 118 |
| 2009 | 117 |
| Revvity Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 120 |
| 2024-12-31 | 123 |
| 2024-09-30 | 123 |
| 2024-06-30 | 123 |
| 2024-03-31 | 124 |
| 2023-12-31 | 125 |
| 2023-09-30 | 124 |
| 2023-06-30 | 125 |
| 2023-03-31 | 126 |
| 2022-12-31 | 126 |
| 2022-09-30 | 127 |
| 2022-06-30 | 127 |
| 2022-03-31 | 127 |
| 2021-12-31 | 117 |
| 2021-09-30 | 115 |
| 2021-06-30 | 112 |
| 2021-03-31 | 112 |
| 2020-12-31 | 112 |
| 2020-09-30 | 112 |
| 2020-06-30 | 112 |
| 2020-03-31 | 112 |
| 2019-12-31 | 112 |
| 2019-09-30 | 112 |
| 2019-06-30 | 112 |
| 2019-03-31 | 111 |
| 2018-12-31 | 112 |
| 2018-09-30 | 112 |
| 2018-06-30 | 111 |
| 2018-03-31 | 111 |
| 2017-12-31 | 111 |
| 2017-09-30 | 111 |
| 2017-06-30 | 111 |
| 2017-03-31 | 110 |
| 2016-12-31 | 110 |
| 2016-09-30 | 110 |
| 2016-06-30 | 110 |
| 2016-03-31 | 111 |
| 2015-12-31 | 113 |
| 2015-09-30 | 113 |
| 2015-06-30 | 114 |
| 2015-03-31 | 113 |
| 2014-12-31 | 114 |
| 2014-09-30 | 114 |
| 2014-06-30 | 114 |
| 2014-03-31 | 114 |
| 2013-12-31 | 114 |
| 2013-09-30 | 113 |
| 2013-06-30 | 113 |
| 2013-03-31 | 115 |
| 2012-12-31 | 115 |
| 2012-09-30 | 115 |
| 2012-06-30 | 115 |
| 2012-03-31 | 114 |
| 2011-12-31 | 114 |
| 2011-09-30 | 113 |
| 2011-06-30 | 114 |
| 2011-03-31 | 115 |
| 2010-12-31 | 118 |
| 2010-09-30 | 118 |
| 2010-06-30 | 118 |
| 2010-03-31 | 118 |
| 2009-12-31 | 117 |
| 2009-09-30 | 117 |
| 2009-06-30 | 116 |
| 2009-03-31 | 117 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.635B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.869B | 26.80 |
| CVS Health (CVS) | United States | $84.351B | 10.48 |
| Elevance Health (ELV) | United States | $78.372B | 10.11 |
| Cencora (COR) | United States | $58.632B | 20.40 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $21.669B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.584B | 17.51 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.511B | 0.00 |
| Solventum (SOLV) | United States | $13.191B | 13.96 |
| CochLear (CHEOY) | Australia | $12.755B | 0.00 |
| ICON (ICLR) | Ireland | $11.919B | 11.08 |
| Viatris (VTRS) | United States | $10.798B | 3.71 |
| Avantor (AVTR) | United States | $9.206B | 13.38 |
| Medpace Holdings (MEDP) | United States | $9.166B | 24.34 |
| HealthEquity (HQY) | United States | $8.806B | 38.57 |
| Sonic Healthcare (SKHHY) | Australia | $8.474B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.559B | 14.81 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.749B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.885B | 28.77 |
| BrightSpring Health Services (BTSG) | United States | $3.868B | 35.48 |
| Sotera Health (SHC) | United States | $3.236B | 18.39 |
| Surgery Partners (SGRY) | United States | $2.823B | 36.72 |
| Concentras Parent (CON) | United States | $2.608B | 15.07 |
| Alignment Healthcare (ALHC) | United States | $2.600B | 0.00 |
| Organon (OGN) | United States | $2.527B | 2.69 |
| GeneDx Holdings (WGS) | United States | $2.446B | 94.22 |
| Ardent Health (ARDT) | United States | $1.902B | 8.11 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Progyny (PGNY) | United States | $1.839B | 40.47 |
| Premier (PINC) | United States | $1.812B | 13.75 |
| GoodRx Holdings (GDRX) | United States | $1.693B | 33.86 |
| Teladoc Health (TDOC) | United States | $1.416B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.333B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.155B | 8.79 |
| CareDx (CDNA) | United States | $1.027B | 16.04 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.965B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.813B | 7.61 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Nutex Health (NUTX) | United States | $0.698B | 10.57 |
| Embecta (EMBC) | United States | $0.586B | 3.95 |
| InnovAge Holding (INNV) | United States | $0.563B | 0.00 |
| LifeMD (LFMD) | United States | $0.554B | 0.00 |
| Omada Health (OMDA) | $0.481B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.467B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
| So-Young (SY) | China | $0.436B | 0.00 |
| Enhabit (EHAB) | United States | $0.371B | 30.50 |
| Performant Healthcare (PHLT) | United States | $0.329B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.310B | 0.00 |
| Beauty Health (SKIN) | United States | $0.277B | 0.00 |
| Oncology Institute (TOI) | United States | $0.228B | 0.00 |
| DocGo (DCGO) | United States | $0.155B | 25.33 |
| Pheton Holdings (PTHL) | China | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.091B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| OpGen (OPGN) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.026B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |